Dr. Ivan Bergstein, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 28 Arleigh Rd, Great Neck, NY 11021 Phone: 917-992-2168 |
Dr. Fakhiuddin Ahmed, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 11 Mirrielees Cir, Great Neck, NY 11021 Phone: 516-487-2366 Fax: 516-487-2058 |
Dr. Hal Gerstein, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 225 Community Dr, Suite 160, Great Neck, NY 11021 Phone: 516-482-4790 Fax: 516-773-3708 |
Dr. Julia Mandelblat, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 7 Stoner Ave, Great Neck, NY 11021 Phone: 917-601-0824 |
News Archive
The General Chapter of Royal Arch Masons International presented Autism Speaks, the world's largest autism research and advocacy organization, with a $100,000 Royal Arch Research Assistance (RARA) grant in support of the Autism Speaks early diagnosis and early intervention initiative to investigate auditory processing disorders in children with autism.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced data from a Phase 2 clinical trial that demonstrated Positron Emission Tomography myocardial perfusion imaging with flurpiridaz F 18 provided superior image quality, diagnostic certainty and diagnostic performance for detecting coronary artery disease (CAD) compared to single photon emission computed tomography myocardial perfusion imaging, the current standard for the non-invasive detection of CAD.
Oncotarget published "Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib" which reported that this study investigated the association of the IGF/CTP score with overall survival and progression-free survival of HCC patients treated with sorafenib.
Researchers from the Children's Hospital, Boston, USA and the Center for Science in the Public Interest, Washington, D. C., USA, have found that there is a high potential for research findings into non-alcoholic drinks to be affected by bias from companies providing funding.
› Verified 4 days ago